Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:35 PM
NCT ID:
NCT04428151
Pre Assignment Details:
Protocol-specified final analysis for the results, including participant flow, was performed on 374 participants enrolled within the primary completion data cut-off. Analysis of the remaining 34 participants will be included in the End of Trial analysis.
Participants who experienced progressive disease in the lenvatinib monotherapy or Standard of Care arms could switch over to receive lenvatinib + pembrolizumab. One participant switched over and received only pembrolizumab.
Study:
NCT04428151
Study Brief:
Results Section:
NCT04428151